$DCO

Ducommun Q2 Earnings Call Highlights

Ducommun (NYSE:DCO) reported Q2 adjusted EBITDA of $38.4M (17.1% of revenue) versus $31.7M a year earlier. GAAP net income rose to $20.4M ($1.31/share). Defense revenue was $124M, up to missile growth, and remaining performance obligations hit a record $1.16B. Commercial aerospace revenue rose to $89M. CFO cited a one-time compensation clawback.

Original reporting
Published Aug 9, 2026, 9:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 9, 2026, 9:16 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ducommun Q2 Earnings Call Highlights — source image
Decision brief

The 30-second read

$DCOBullishMed
01

Why it matters

Key trading takeaways are (1) defense missile growth accelerating, (2) record remaining performance obligations and strong book-to-bill, and (3) improved cash flow and liquidity, partially offset by commercial aerospace destocking headwinds.

02

Market read

For traders, the combination of missile-led defense growth, record backlog, and reiterated full-year growth guidance provides a near-term fundamental catalyst for DCO positioning.

03

What to watch

Backlog excludes potential share of orders from certain multiyear missile framework agreements, so upside may be understated, but timing risk remains given order timing commentary.

Relevance 7/10Novelty 6/10Timing: pre-market today, Q2 earnings call highlights and 2026 growth outlook

Background

The piece summarizes Ducommun’s Q2 earnings call, focusing on adjusted profitability, defense missile growth, commercial aerospace deliveries, backlog, and 2026 guidance.

Company-level read

Ticker impact

$DCOBullishMedium confidence
Context

Ducommun reported Q2 results and reiterated 2026 revenue growth expectations, with defense missile growth and a record $1.16B backlog.

Expected impact

Likely modest positive bias for DCO as traders price in stronger defense order momentum and improved cash generation, though guidance is only reiterated.

Evidence & confidence

The article provides multiple concrete operating datapoints (EBITDA, net income, missile growth, bookings, backlog, liquidity) and a specific 2026 growth range, which can move sentiment, but it is still an earnings-call highlight rather than a surprise guidance change.

Market effects

Reinforces demand strength in defense electronics and missile-related supply chains, potentially supporting sentiment for similarly positioned aerospace and defense suppliers.

Limited direct regional spillover; primarily US defense/aerospace supply-chain sentiment.

Moderate, as the backlog and missile program ramp are US-led but can influence broader defense procurement expectations.

Counterpoint

Commercial aerospace destocking is still a headwind through the remainder of 2026, which could cap upside if defense growth does not fully offset it.

Key entities

  • Ducommun Incorporated

    NYSE-listed aerospace and defense supplier reporting Q2 results and 2026 growth expectations.

  • Vision 2027 plan

    Targets adjusted EBITDA margin of 18% in 2027.

  • Vision 2032 investor day

    Scheduled for Sept. 17 in New York.

Related articles

$DCOMed

DUCOMMUN INC /DE/ (DCO): Results of Operations and Financial Condition

DUCOMMUN INC /DE/ (DCO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 dcoex99_1q22026earningsrel.htm EX-99.1 Document EXHIBIT 99.1 NEWS RELEASE Ducommun Incorporated Reports Second Quarter 2026 Results Record Revenue and Gross Margin; Remaining Performance Obligations at All-Time High COSTA MESA, CALIFORNIA (August 6, 2026) – Ducommun Inc

$TPBMedAI 8/10

Turning Point Brands Q2 Earnings Call Highlights

Turning Point Brands (NYSE:TPB) reported Q2 segment updates and raised 2026 Modern Oral outlook. Adjusted gross sales guidance for Modern Oral increased to $330M-$350M and net sales to $260M-$270M. It kept full-year adjusted EBITDA at $70M-$90M. The company said it ended Q2 with $268M cash and $26M free cash flow, helped by an $18M tariff refund.

$FIGSHighAI 9/10

FIGS Q2 Earnings Call Highlights

FIGS (NYSE:FIGS) reported Q2 results and an earnings call update. International revenue rose 67% to $37.9M and U.S. revenue grew 22% to $158.7M. Gross margin increased to 75.2% with a $15.4M tariff refund benefit. Net income was $28.4M, or $0.15/share. FIGS raised FY2026 revenue growth to ~20% and operating margin to ~10.8%, and repurchased about $24M of shares.

$ELFMedAI 8/10

Rhode Is Fueling e.l.f.'s Latest Surge. Is It Time to Jump In?

e.l.f. Beauty (ELF) shares rose after the company reported fiscal Q1 results and raised full-year guidance. Sales grew 36% to $479.4M and adjusted EPS rose to $1.75 (traffic refund noted). Rhode contributed $160M sales. Full-year revenue guidance increased to $1.938B-$1.968B and adjusted EPS to $3.50-$3.55.

$FNFMed

Fidelity National Financial Q2 Earnings Call Highlights

Fidelity National Financial (FNF) Q2 call discussed low existing-home sales amid higher mortgage rates, but daily purchase orders rose 3% YoY and 7% QoQ. Refinance orders averaged 1,600/day in Q2. Commercial direct revenue was $778M in H1 2026 (+24% YoY). F&G AUM was $74.7B; adjusted earnings fell to $65M. FNF returned $195M to shareholders.

$TNCMedAI 8/10

Tennant Q2 Earnings Call Highlights

Tennant (NYSE:TNC) reported Q2 supply-chain disruptions tied to ERP demand-signal issues and North America demand pressure. Robotics revenue rose 37% to about $31M in Q2, and first-half robotics revenue rose 56% to $58M. Management expects Q3 parts availability improving mid-quarter. Full-year guidance: net sales $1.27B-$1.31B, adjusted EBITDA $155M-$170M, GAAP EPS $2.15-$2.80.